1201 Hadley Rd, Mooresville, IN, 46158 · (317) 831-1160
Beds
80
FY 2025
Star rating
5 of 5
Patient survey: 4 of 5
Net patient revenue
$158.0M
FY 2025
Net income
$48.6M
Patient care margin 5.7%
Discharges
2,524
Occupancy 26.0%
Clinicians
488
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $158.0M | $148.9M | 5.7% | $48.6M | 2,524 | $6.1M | 25.6% | 0.3% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for COPD patients | 7.4% | US median 8.5% |
| Death rate for heart failure patients | 11.2% | US median 11% |
| Hospital-wide death rate within 30 days | 3.9% | US median 3.9% |
| Death rate for pneumonia patients | 14.3% | US median 15.2% |
| Death rate for stroke patients | 12.9% | US median 11.6% |
| Readmission rate for COPD | 20.6% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $131.7M | $138.3M | -5.0% | $11.8M | 2,307 | $4.7M | 26.2% | 0.5% |
| 2023 | $152.3M | $118.7M | 22.0% | $43.0M | 2,307 | $6.2M | 29.9% | 0.6% |
| 2022 | $157.3M | $116.1M | 26.2% | $50.9M | 2,256 | $5.9M | 30.8% | 0.4% |
| 2021 | $177.6M | $99.7M | 43.9% | $47.6M | 2,238 | $5.6M | 29.4% | 0.4% |
| 2020 | $140.1M | $91.4M | 34.7% | $56.4M | 2,406 | $6.0M | 36.9% | 7.1% |
| US median 19.8% |
| Readmission rate for heart failure | 20% | US median 21.3% |
| Readmission rate after hip or knee replacement | 5% | US median 5.8% |
| Readmission rate for pneumonia | 18% | US median 17.2% |
| Complications after hip or knee replacement | 4% | US median 4.1% |
| Serious complications (patient safety composite) | 0.83 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.83 | US median 0.28 |
| Surgical site infections after colon surgery (ratio to expected) | 1.12 | US median 0.72 |
| Doctors always communicated well | 84% | US median 79% |
| Nurses always communicated well | 80% | US median 80% |
| Patient survey summary star rating | 4 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 63% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 78% | US median 72% |
| Room and bathroom always clean | 67% | US median 73% |
| Patients who would definitely recommend the hospital | 77% | US median 71% |
| Patients who left the emergency department before being seen | 0% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 126 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 20% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 64% | US median 65% |
| Healthcare workers given the flu vaccine | 88% | US median 79% |
| 40 |
| $42,628.73 |
| $10,637.68 |
| $9,867.73 |
| DRG 189 PULMONARY EDEMA AND RESPIRATORY FAILURE | 30 | $33,596.73 | $9,246.50 | $9,973.97 |
| DRG 467 REVISION OF HIP OR KNEE REPLACEMENT WITH CC | 30 | $112,211.10 | $25,669.43 | $26,100.04 |
| DRG 177 RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC | 27 | $42,596.37 | $13,259.22 | $12,667.88 |
| DRG 470 MAJOR HIP AND KNEE JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MCC | 26 | $80,896.12 | $14,295.58 | $14,289.25 |
| DRG 468 REVISION OF HIP OR KNEE REPLACEMENT WITHOUT CC/MCC | 26 | $104,377.50 | $21,110.15 | $19,721.95 |
| DRG 330 MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH CC | 21 | $90,986.19 | $16,518.52 | $18,026.21 |
| DRG 690 KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC | 16 | $28,451.50 | $7,048.69 | $5,985.69 |
| DRG 872 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC | 15 | $30,738.53 | $7,934.93 | $7,681.44 |
| DRG 689 KIDNEY AND URINARY TRACT INFECTIONS WITH MCC | 15 | $40,348.27 | $9,847.47 | $8,838.11 |
| DRG 331 MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT CC/MCC | 12 | $75,283.33 | $13,424.50 | $12,052.70 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5115 Level 5 Musculoskeletal Procedures | 284 | 275 | $10,167.77 | $10,771.69 |
| APC 8011 Comprehensive Observation Services | 86 | 84 | $1,968.09 | $2,090.36 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 28 | 27 | $1,162.68 | $1,219.56 |
| APC 5112 Level 2 Musculoskeletal Procedures | 12 | 12 | $1,147.52 | $1,196.16 |
| APC 5114 Level 4 Musculoskeletal Procedures | - | - | - | $5,338.75 |
| APC 5116 Level 6 Musculoskeletal Procedures | - | - | - | $15,762.73 |
| APC 5182 Level 2 Vascular Procedures | - | - | - | $1,204.32 |
| APC 5313 Level 3 Lower GI Procedures | - | - | - | $2,176.09 |
| APC 5331 Complex GI Procedures | - | - | - | $4,262.70 |
| APC 5341 Level 1 Abdominal/Peritoneal/Biliary and Related Procedures | - | - | - | $2,635.67 |
| APC 5361 Level 1 Laparoscopy and Related Services | - | - | - | $4,357.80 |
| APC 5362 Level 2 Laparoscopy and Related Services | - | - | - | $8,164.45 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 6 | $127K |
| Pfizer Inc. PFE | 16 | $59K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $44K |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $37K |
| LivaNova USA, Inc. LIVN | 1 | $27K |
| Esperion Therapeutics, Inc. ESPR | 3 | $8,140 |
| Celgene Corporation BMY | 1 | $6,375 |
| Zimmer Biomet Holdings, Inc. ZBH | 2 | $3,316 |
| Olympus America Inc. | 1 | $1,429 |
| Incyte Corporation INCY | 2 | $823 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Franciscan Health Mooresville is a nonprofit short-term acute care hospital in Mooresville, IN with 80 beds, part of Franciscan Health and a 5-star overall rating.
Franciscan Health Mooresville in Mooresville, IN has 80 beds (fiscal year 2025 cost report); 82 beds are certified for Medicare. It discharged 2,524 inpatients that year, with 26.0% of its beds in use on average.
In fiscal year 2025 (ending 2025-12-31), Franciscan Health Mooresville reported net patient revenue of $158.0M and operating expenses of $148.9M, a margin on patient care of 5.7%. After other income and expenses its net income was $48.6M (24.6% of revenue), so it made a profit that year.
Franciscan Health Mooresville is part of Franciscan Health, a health system with 10 hospitals based in Mishawaka, IN. It is a nonprofit hospital.
Franciscan Health Mooresville has an overall rating of 5 out of 5 stars in the official hospital quality ratings. Patients rate it 4 out of 5 stars in the patient survey.
Yes, Franciscan Health Mooresville provides emergency services.
488 Medicare clinicians list Franciscan Health Mooresville as a hospital they work at, most often in Nurse Practitioner, Physician Assistant, Family Practice.
In 2024, Franciscan Health Mooresville had 373 Medicare inpatient stays in 13 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 73 stays; Medicare paid $15,068.62 per stay on average, compared with $15,524.21 across all hospitals.
In 2023, companies reported $314K in payments to Franciscan Health Mooresville as a teaching hospital ($29K general and $286K for research) from 10 companies.